Crf receptor antagonists and methods relating thereto

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/16 (2006.01) A61K 31/4985 (2006.01) A61K 31/551 (2006.01) A61P 25/00 (2006.01) C07D 221/00 (2006.01) C07D 235/00 (2006.01) C07D 239/00 (2006.01) C07D 241/00 (2006.01) C07D 243/00 (2006.01) C07D 471/16 (2006.01)

Patent

CA 2349904

Compounds are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in warmblooded animals, including stroke. The compounds of this invention have structures (I): (a) wherein n, m, R, R1, R2, X and Ar are as defined herein, including stereoisomes and pharmaceutically acceptable salts thereof.

L'invention concerne des composés qui sont utiles dans le traitement de diverses affections, notamment dans le traitement d'affections dans lesquelles on observe une hypersécrétion de CRF chez les animaux à sang chaud, en particulier les accidents vasculaires cérébraux. Les composés de l'invention présentent la structure de la formule (I), dans laquelle n, m, R, R¿1?, R¿2?, X et Ar sont tels que définis dans le descriptif, y compris leurs stéréoisomères et leurs sels acceptables sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Crf receptor antagonists and methods relating thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crf receptor antagonists and methods relating thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crf receptor antagonists and methods relating thereto will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1776766

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.